Hanson McClain Advisors »

Cara Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Cara Therapeutics (CARA) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Cara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cara Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cara Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $655 719 0.91
2023-12-31 $535 719 0.74
2023-09-30 $1.2k 719 1.68
2023-06-30 $2.0k 719 2.83
2023-03-31 $3.5k 719 4.91
2022-12-31 $8.0k 749 10.74
2022-09-30 $7.0k 719 9.74
2022-06-30 $7.0k 719 9.74
2022-03-31 $9.0k 719 12.52
2021-12-31 $9.0k 762 11.81
2021-09-30 $12k 762 15.75
2021-06-30 $11k 762 14.44
2021-03-31 $17k 762 22.31
2020-12-31 $11k 719 15.30
2020-09-30 $9.0k 719 12.52
2020-06-30 $12k 719 16.69
2020-03-31 $9.0k 719 12.52
2019-12-31 $12k 719 16.69
2019-09-30 $13k 719 18.08
2019-06-30 $15k 719 20.86
2019-03-31 $14k 719 19.47
2018-12-31 $8.0k 581 13.77
2018-09-30 $14k 581 24.10
2018-06-30 $11k 581 18.93